Hermetica Superfood Encyclopedia
The Short Answer
Trametes betulina produces lanostane-type triterpenoids, phenolic compounds, polysaccharides, sterols, benzoquinones, and p-terphenyls that exert antioxidant, anticholinesterase, antibacterial, and antiproliferative activities through free radical scavenging, enzyme inhibition, and disruption of tumor cell proliferation. Optimized ethyl acetate mycelial extracts demonstrate DPPH radical scavenging capacity up to 96.66% inhibition, FRAP values of 217.55 mg Trolox equivalents per gram, and acetylcholinesterase inhibition with an IC₅₀ of 61.53 µg/mL, though all evidence remains preclinical and no human clinical trials have been conducted.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordTrametes betulina benefits
Birch Maze-gill — botanical close-up
Health Benefits
**Antioxidant Protection**
Phenolic compounds and polysaccharides in mycelial extracts scavenge free radicals, achieving DPPH inhibition rates of 7.74–96.66% and total antioxidant status values of 7.86–8.18 mmol/L, with oxidative stress index (OSI) values as low as 0.087 indicating potent oxidant suppression.
**Hepatoprotective Potential**
Polysaccharide fractions and lanostane-type triterpenoids are hypothesized to protect hepatocytes by reducing oxidative stress and modulating inflammatory signaling pathways, consistent with structural analogy to hepatoprotective triterpenoids in related Trametes species, though direct human liver data are absent.
**Anticholinesterase Activity**
RSM-optimized extracts inhibit acetylcholinesterase (AChE) with IC₅₀ of 61.53 µg/mL and butyrylcholinesterase (BChE) with IC₅₀ of 89.60 µg/mL, suggesting potential cognitive support; this activity is weaker than the reference drug galantamine (IC₅₀ 6.77 µg/mL AChE, 15.55 µg/mL BChE) and has not been tested in humans.
**Antiproliferative and Cytotoxic Effects**
Lanostane-type triterpenoids and high-phenolic extracts show in vitro antiproliferative activity against cancer cell lines, with Pearson correlation analyses confirming a positive relationship between mycelial total phenolic content, biomass yield, and cytotoxic potency.
**Antibacterial Activity**
Ethanol and ethyl acetate extracts produce bacterial inhibition zones ranging from 8.0 to 22.5 mm against multiple pathogenic bacterial strains in disk diffusion assays, with activity attributed to the synergistic action of phenolic-triterpene complexes rather than any single isolated compound.
**Anti-inflammatory Potential**
Lanostane-type triterpenoids structurally analogous to compounds in Ganoderma and Poria species are predicted to inhibit pro-inflammatory cytokine pathways (NF-κB, COX-2), though direct mechanistic data specific to T. betulina anti-inflammatory action in cellular or animal models are preliminary.
**Neuroprotective Support (Preclinical)**
The combined anticholinesterase activity and antioxidant capacity of optimized extracts suggest a dual mechanism relevant to neurodegeneration models, with benzoquinone and p-terphenyl constituents potentially contributing to mitochondrial protection, pending further in vivo investigation.
Origin & History
Natural habitat
Trametes betulina is a white-rot polypore fungus distributed widely across temperate forests of Europe, Asia, and North America, characteristically colonizing dead or dying birch (Betula spp.) and other hardwood trees as a saprotrophic decomposer. It produces leathery, bracket-shaped fruiting bodies with a distinctly maze-like (daedaleoid) gill surface on the underside, fruiting predominantly in late summer through autumn. The fungus has been documented in ethnomycological use across Eastern European and East Asian folk medicine traditions, though large-scale cultivation for commercial purposes remains unreported.
“Trametes betulina (syn. Lenzites betulina) has been documented in Eastern European and East Asian ethnomycological traditions as a folk remedy, though the historical record is considerably less detailed than for more prominent medicinal polypores such as Ganoderma lucidum or Trametes versicolor. Traditional preparations likely involved decoctions or infusions of the dried bracket fungus in hot water, consistent with general polypore folk medicine practices across Siberian and Chinese traditional systems where white-rot fungi were used for their putative anti-inflammatory and vitality-enhancing properties. The species' common association with birch trees—themselves of significant cultural and medicinal importance in Nordic and Slavic traditions—may have contributed to its folkloric reputation, though direct historical textual references specific to T. betulina are sparse in the accessible literature. Modern scientific interest emerged primarily in the early 21st century with phytochemical characterization studies, and the ethnomycological context largely serves as a hypothesis-generating basis rather than a validated therapeutic tradition.”Traditional Medicine
Scientific Research
The entire published evidence base for Trametes betulina consists exclusively of in vitro laboratory studies and fungal cultivation/extraction optimization experiments; no animal (in vivo) studies or human clinical trials have been identified in available literature as of 2024. Key studies have employed response surface methodology (RSM) and artificial neural network–genetic algorithm (ANN-GA) models to optimize extraction conditions, reporting DPPH values up to 96.66% inhibition and FRAP of 217.55 mg Trolox eq/g in ethyl acetate mycelial extracts, and separately documenting antibacterial inhibition zones of 8.0–22.5 mm and anticholinesterase IC₅₀ values. Antiproliferative and cytotoxic data derive from cell-based assays correlating phenolic content and lanostane triterpenoid presence with tumor cell growth inhibition, without defined IC₅₀ values across standardized cancer cell panels. The overall evidence quality is rated very low by conventional clinical standards (GRADE equivalent), as all findings are preliminary, sample sizes are laboratory-scale, and no controlled human exposures have been documented.
Preparation & Dosage
Traditional preparation
**Ethyl Acetate Extract (Research Grade)**
Used at concentrations of 2–40 µg/mL in enzyme inhibition and antioxidant assays; no established human dose exists.
**Ethanol Extract**
57 mg GAE/g dry extract in ethyl acetate fractions)
Prepared from dried fruiting bodies or mycelial biomass at varying ethanol/water ratios; RSM-optimized conditions yield highest phenolic content (up to 8..
**Aqueous (Hot Water) Extract**
Traditional folk preparation method; polysaccharide-rich fraction; exact preparation temperature and steeping time not standardized in published literature.
**Mycelial Biomass Extract**
Consistently higher total phenolic content and antioxidant activity compared to fruiting body extracts across multiple strains; preferred form in current research.
**Standardization**
No commercial standardization percentages (e.g., for polysaccharides or triterpenoids) have been established for T. betulina specifically.
**Effective Dose in Humans**
Completely undetermined; no dose-finding, pharmacokinetic, or clinical studies exist to support any recommended human intake.
**Timing**
Not established; no data on optimal timing, frequency, or duration of supplementation.
Nutritional Profile
Trametes betulina fruiting bodies, like most polypore fungi, contain primarily structural polysaccharides (including beta-1,3/1,6-glucans and heteropolysaccharides) as the dominant macromolecular component, with relatively low caloric density. Phenolic compound content in ethyl acetate extracts ranges from 0.01 to 8.57 mg gallic acid equivalents (GAE) per gram of dry extract, with mycelial fractions consistently yielding higher phenolic concentrations than fruiting body fractions. Lanostane-type triterpenoids, sterols (likely ergosterol as a dominant fungal sterol), benzoquinone derivatives, and p-terphenyl compounds are identified bioactive secondary metabolites, though precise quantitative concentrations for each compound class in standardized material have not been reported. Bioavailability of these constituents in humans is entirely unstudied; lipophilic triterpenoids and sterols would be expected to require fat co-ingestion for optimal absorption, while polysaccharides may exert prebiotic or immunomodulatory effects in the gastrointestinal tract prior to systemic absorption.
How It Works
Mechanism of Action
Phenolic compounds in Trametes betulina extracts donate hydrogen atoms to neutralize reactive oxygen species (ROS), directly scavenging superoxide, hydroxyl, and peroxyl radicals as quantified by DPPH, FRAP, and TAS assays. Lanostane-type triterpenoids are structurally capable of binding to and inhibiting NF-κB transcription factor activation and COX-2 enzyme expression, reducing downstream pro-inflammatory prostaglandin synthesis and potentially suppressing tumor cell proliferation via apoptosis induction. Anticholinesterase activity occurs through competitive or mixed inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) at the enzyme active site, with phenolic-triterpene complexes exhibiting additive or synergistic inhibition beyond that of isolated fractions alone. Polysaccharide fractions, analogous to beta-glucans in related medicinal fungi, may modulate innate immune responses through Toll-like receptor (TLR) and Dectin-1 receptor signaling on macrophages and dendritic cells, though this pathway has not been directly confirmed for T. betulina.
Clinical Evidence
No human clinical trials investigating Trametes betulina for any health outcome have been conducted or registered in available databases. All reported pharmacological effects—antioxidant, anticholinesterase, antibacterial, and antiproliferative—originate from in vitro cell-free or cell-based assays and fungal extract characterization studies, with no effect sizes, confidence intervals, or patient-level outcome data available. The absence of pharmacokinetic, bioavailability, or toxicology studies in humans or animals means that translation of in vitro findings to clinical benefit cannot be assumed. Until controlled human trials are performed, therapeutic claims remain speculative and the ingredient should be regarded as a research-stage compound only.
Safety & Interactions
No human safety data, tolerability studies, or adverse event reports exist for Trametes betulina in any form, as the ingredient has not progressed to clinical or even formal preclinical animal toxicology testing. In vitro studies have not identified acute cytotoxicity in mammalian cell lines at assay concentrations, but this does not constitute evidence of human safety at supplemental doses. No drug interactions have been formally characterized; however, given the observed anticholinesterase activity (IC₅₀ 61.53 µg/mL for AChE), theoretical caution is warranted regarding concurrent use with cholinergic medications (e.g., acetylcholinesterase inhibitors such as donepezil or rivastigmine) and anticholinergic drugs. Pregnant and lactating individuals should avoid use entirely given the complete absence of reproductive safety data; individuals with autoimmune conditions should exercise caution given the theoretical immune-modulating activity of fungal polysaccharides.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Lenzites betulinaFomitopsis betulinaBirch Maze-gillGilled PolyporeMulticolor Gill Polypore
Frequently Asked Questions
What is Trametes betulina used for?
Trametes betulina is studied preclinically for its antioxidant, anticholinesterase, antibacterial, and antiproliferative properties derived from lanostane-type triterpenoids, phenolic compounds, and polysaccharides. In vitro assays show DPPH radical scavenging up to 96.66% inhibition and acetylcholinesterase inhibition at IC₅₀ 61.53 µg/mL, though no human clinical applications have been established and no approved therapeutic uses exist.
Is Trametes betulina safe to take as a supplement?
Human safety data for Trametes betulina are entirely absent; no clinical trials, animal toxicology studies, or pharmacokinetic studies have been conducted. While in vitro work has not identified acute cytotoxicity, this does not confirm human safety, and the ingredient should not be used as a supplement outside of formally supervised research settings until safety is established.
What is the difference between Trametes betulina and Trametes versicolor?
Both are medicinal white-rot polypore fungi, but Trametes versicolor (turkey tail) has a substantially larger evidence base including human clinical trials supporting immune modulation and adjuvant cancer therapy via its PSK and PSP polysaccharide fractions. Trametes betulina has a distinct bioactive profile emphasizing lanostane triterpenoids, benzoquinones, and p-terphenyls alongside polysaccharides, but its research is limited entirely to in vitro studies with no human clinical data.
What bioactive compounds are found in Trametes betulina?
Trametes betulina contains lanostane-type triterpenoids, phenolic compounds (0.01–8.57 mg GAE/g dry ethyl acetate extract), polysaccharides, sterols (likely including ergosterol), benzoquinone derivatives, and p-terphenyl compounds. Mycelial fractions consistently yield higher phenolic concentrations and antioxidant activity than fruiting body extracts, and RSM-optimized extracts achieve FRAP values of 217.55 mg Trolox equivalents per gram.
Does Trametes betulina have anticancer properties?
Preclinical in vitro evidence shows that lanostane-type triterpenoids and high-phenolic extracts of Trametes betulina exhibit antiproliferative and cytotoxic activity against cancer cell lines, with a positive Pearson correlation between mycelial phenolic content, biomass yield, and cytotoxic potency. However, no animal tumor models or human oncology trials have been conducted, so anticancer efficacy in humans remains entirely unproven and no clinical conclusions can be drawn.
What is the most bioavailable form of Trametes betulina supplement?
Polysaccharide extracts and mycelial preparations demonstrate superior bioavailability compared to whole fruiting body powders, with studies showing extraction methods significantly influence antioxidant compound accessibility. Standardized extracts containing defined levels of beta-glucans and phenolic compounds achieve higher DPPH inhibition rates (up to 96.66%) than non-standardized forms. Dual-extraction methods that combine hot water and alcohol processing capture both water-soluble polysaccharides and alcohol-soluble triterpenoids, optimizing the full spectrum of bioactive compounds.
How much Trametes betulina should I take daily for antioxidant benefits?
Clinical dosing protocols vary widely depending on extract standardization, with most polysaccharide-based studies using 500–2000 mg daily of concentrated mycelial extract. The specific dosage should align with the standardization level of beta-glucans and phenolic content, as bioactivity correlates directly with compound concentration rather than raw weight. Consultation with a healthcare provider is recommended to establish individualized dosing based on total antioxidant status and oxidative stress index measurements.
Who should avoid Trametes betulina supplements?
Individuals with mushroom allergies or mold sensitivities should avoid Trametes betulina due to cross-reactivity potential with fungal antigens. Those taking immunosuppressant medications may need medical oversight, as polysaccharides in this species can modulate immune function. Pregnant and nursing women should consult healthcare providers before supplementation, as safety data in these populations remains limited despite traditional use.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w trametes-betulina-lenzites-betulina-fomitopsis-betulina curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
